Circulating levels of citrullinated and MMP-degraded vimentin (VICM) in liver fibrosis related pathology

American Journal of Translational Research

Volumn 4, Issue 4, 2012, Pages 403-414

  Vassiliadis, Efstathios ^a,b   Oliveira, Claudia P ^f   Alvares da Silva, Mario R ^g   Zhang, Chen ^a,c   Carrilho, Flair J ^f   Stefano, Jose T ^f   Rabelo, Fabiola ^f   Pereira, Leila ^h   Kappel, Camila R ^g   Henriksen, Kim ^a   Veidal, Sanne Skovgård ^a,b   Vainer, Ben ^d   Duffin, Kevin L ^e   Christiansen, Claus ^a   Leeming, Diana J ^a   Karsdal, Morten ^a  

^a NORDIC BIOSCIENCE A S   (Denmark)

^b UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^c TECHNICAL UNIVERSITY OF DENMARK   (Denmark)

^d Rigshospitalet   (Denmark)

^e ELI LILLY AND COMPANY   (United States)

^f UNIVERSITY OF SÃO PAULO   (Brazil)

^g HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^h Instituto do Figado de Pernambuco   (Brazil)

Author keywords

Biomarker; Citrulline; Hepatitis C; NAFLD

Indexed keywords

ANTIGEN; CARBON TETRACHLORIDE; CITRULLINE; MATRIX METALLOPROTEINASE; MONOCLONAL ANTIBODY; VIMENTIN;

ADULT; AGED; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ARTICULAR CARTILAGE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HEPATITIS C; HUMAN; HUMAN TISSUE; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; MASS SPECTROMETRY; NONALCOHOLIC FATTY LIVER; NONHUMAN; RAT; RHEUMATOID ARTHRITIS;

ANIMALIA; HEPATITIS C VIRUS; RATTUS;

EID: 84868008108     PISSN: None     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Charles Streuli. Extracellular matrix remodelling and cellular differentiation. Current Opinion in Cell Biology 1999; 11: 634-640.
2. Shigeki Tsukadaa, Christopher J. Parsonsb, and Richard A. Rippe. Mechanisms of liver fibrosis. Clinica Chimica Acta 2006; 364: 33-60.
3. Schuppan D, Ruehl M, Somasundaram R, and Hahn EG. Matrix as a modulator of hepatic fibrogenesis. Semin Liver Dis 2001; 21: 351- 372
4. Copple BL, Allen K, and Welch TP. Mechanisms of Liver Fibrosis. Comprehensive Toxicology 2010; 9: 263-274.
5. Schuppan D, Ruehl M, Somasundaram R, and Hahn EG. Matrix as a modulator of hepatic fibrogenesis. Semin Liver Dis 2001; 21: 351-372.
6. Veidal SS, Vassiliadis E, Bay-Jensen AC, Tougas G, Vainer B, and Karsdal MA. Procollagen type I N-terminal propeptide (PINP) is a marker for fibrogenesis in bile duct ligation-induced fibro-sis in rats. Fibrogenesis Tissue Repair 2010; 3: 5.
7. Benyon RC, Arthur MJ. Extracellular Matrix Degradation and the Role of Hepatic Stellate Cells. Semin Liver Dis 2011; 21: 373-384.
8. Amalinei C, Caruntu ID, Giuşca SE, Balan RA. Matrix metalloproteinases involvement in pathologic conditions. Rom J Morphol Embryol 2010; 51: 215-228.
9. Hemmann S, Graf J, Roderfeld M, Roeb E. Expression of MMPs and TIMPs in liver fibrosis - a systematic review with special emphasis on anti-fibrotic strategies. J Hepatol 2007; 46: 955 -975.
10. Arthur MJ. Fibrogenesis II. Metalloproteinases and their inhibitors in liver fibrosis. Am J Physiol Gastrointest Liver Physiol 2000; 279: 245-249.
11. Meri S, Baumann M. Proteomic: Post translational modifications immune responces and current analytical tools. Biomolecular Engineering 2001; 18: 213-220.
12. Karsdal MA, Henriksen K, Leeming DJ, Woodworth T, Vassiliadis E, and Bay Jensen AC. Novel combinations of post transaltional modification (PTM) neo-epitopes provide tissue-specific biochemical markers-are they the cause or the consequence of the disease? Clinical Biochemistry 2010; 43: 793-804.
13. Erikcsson JE, He T, Trejo-Skalli AV, HarmalaBrasken AS, Hellman J, Chou YH, and Goldman RD. Specific in vivo phosphorylation sites determine the assembly dynamics of vimentin intermediate filaments. J Cell Sci 2004; 117: 919-932.
14. Nijenhuis S, Zendman AJ, Vossenaar ER, Pruijn GJ, vanVenrooij WJ. Autoantibodies to citrullinated proteins in rheumatoid arthritis: clinical performance and biochemical aspects of an RA -specific marker. Clin Chim Acta 2004; 350: 17-34.
15. Sghiri R, Khalifa O, Bouajina E, Ben Haj Slama F, Baccouche K, Ben Fredj H, Gaha R, Boukadida J. Presence and diagnostic performances of IgA class antibodies to mutated citrullinated vimentin in rheumatoid arthritis. Joint Bone Spine 2010; 77: 279-280.
16. Goëb V, Jouen F, Gilbert D, Le Loët X, Tron F, Vittecoq O. Diagnostic and prognostic usefulness of antibodies to citrullinated peptides. Joint Bone Spine 2009; 76: 343-349.
17. Ivaska J, Pallari HM, Nevo J, Eriksson JE. Novel functions of vimentin in cell adhesion migration, and signaling. Exp Cell Res 2007; 313: 2050-2062.
18. Asaga H, Yamada M, Senshu T. Selective Deimination of Vimentin in Calcium lonophoreInduced Apoptosis of Mouse Peritoneal Macrophages. Biochem Biophys Res Commun 1998; 243: 641-646.
19. Muller K, Dulku S, Hardwick SJ, Skepper JN, Mitchinson MJ. Changes in vimentin in human macrophages during apoptosis induced by oxidised low density lipoprotein. Atherosclerosis 2001; 156: 133-144.
20. van Gaalen F, loan-Facsinay A, Huizinga TW, Toes RE. The Devil in the Details: The Emerging Role of Anticitrulline Autoimmunity in Rheumatoid Arthritis. J Immunol 2005; 175: 5575-5580.
21. Vossenaar ER, Zendman AJ, van Venrooij WJ, Pruijn GJ. PAD, a growing family of citrullinating enzymes: genes, features and involvement in disease. Bioassays 2003; 25: 1106-1118.
22. Gyorgy B, Toth E, Tarcsa E, Falus A, Buzás EI., Citrullination: A posttranslational modification in health and disease. Int J Biochem Cell Biol 2006; 38: 1662-1677.
23. Tarcsa E, Marekov LN, Mei G, Melino G, Lee SC, Steinert PM. Protein unfolding by peptidylarginine deiminase. Substrate specificity and structural relationships of the natural substrates trichohyalin and filaggrin. J Biol Chem 1996; 271: 30709-30716.
24. Bannister AJ and Kouzarides T. Reversing histone methylation. Nature 2005; 436: 1103-1106.
25. Hochstrasser M. Ubiquitin, proteasomes, and the regulation of intracellular protein degradation. Curr Opin Cell Biol 1995; 7: 215-223.
26. Harauz G, Ishiyama N, Hill CM, Bates IR, Libich DS, Fares C. Myelin basic protein - diverse conformational states of an intrinsically unstructured protein and its roles in myelin assembly and multiple sclerosis. Micron 2004; 35: 503-542.
27. McGraw WT, Potempa J, Farley D, Travis J. Purification, characterization, and sequence analysis of a potential virulence factor from Porphyromonas gingivalis, peptidylarginine deiminase. Infect Immunol 1999; 67: 3248-3256.
28. Ishida-Yamamoto A, Senshu T, Takahashi H, Akiyama K, Nomura K, lizuka H. Decreased deiminated keratin K1 in psoriatic hyperproliferative epidermis. J Invest Dermatol 2000; 114: 701-705.
29. Ehrlich A, Booher S, Becerra Y, Borris DL, Figg WD, Turner ML, Blauvelt A. Micellar paclitaxel improves severe psoriasis in a prospective phase II pilot study. J Am Acad Dermatol 2004; 50: 533-540.
30. Mastronardi FG, Mak B, Ackerley CA, Roots BI, Moscarello MA. Modifications of basic protein in DM20 transgenic mice are similar to those in myelin basic protein from multiple sclerosis. J Clin Invest 1996: 97: 349-358.
31. Nienhuis RL, Mandema E. A new serum factor in patients with rheumatoid arthritis; the antiperinuclear factor. Ann Rheum Dis 1964; 23: 302-305.
32. Schellekens GA, de Jong BA, van den Hoogen FH, van de Putte LB, van Venrooij WJ. Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritisspecific autoantibodies. J Clin Invest 1998; 101: 273-281.
33. Girbal-Neuhauser E, Durieux JJ, Arnaud M, Dalbon P, Sebbag M, Vincent C, Simon M, Senshu T, Masson-Bessière C, Jolivet-Reynaud C, Jolivet M, Serre G. The epitopes targeted by the rheumatoid arthritis-associated antifilaggrin autoantibodies are posttranslationally generated on various sites of (pro) filaggrin by deimination of arginine residues. J Immunol 1999; 162: 585-594.
34. Lutteri L, Malaise M, Chapelle JP. Comparison of second and third generation anti cyclic citrullinated peptide antibodies assays for detecting rheumatoid arthritis. Clinica Chimica Acta 2007; 386: 76-81.
35. Vossenaar ER and van Venrooij WJ. Anti-CCP antibodies, a highly specific marker for (early) rheumatoid arthritis. Clinical and Applied Immunology Reviews 2004; 4: 239-262.
36. Marcelletti JF and Nakamura RM. Assesment of serological markers associated with rheumatoid arthritis: Diagnostic autoantibodies and conventional disease activity markers. Clinical and Applied Immunology Reviews 2003; 4: 109-123.
37. Goldbach-Mansky R, Lee JM, Hoxworth JM, Smith D 2nd, Duray P, Schumacher RH Jr, Yarboro CH, Klippel J, Kleiner D, El-Gabalawy HS. Active synovial matrix metalloproteinase-2 is associated with radiographic erosions in patients with early synovitis. Arthritis Res 2000; 2: 145-153.
38. Goldbach-Mansky R, Lee J, McCoy A, Hoxworth J, Yarboro C, Smolen JS, Steiner G, Rosen A, Zhang C, Ménard HA, Zhou ZJ, Palosuo T, Van Venrooij WJ, Wilder RL, Klippel JH, Schumacher HR Jr, El-Gabalawy HS. Rheumatoid arthritis associated autoantibodies in patients with synovitis of recent onset. Arthritis Res 2000; 2: 236-243.
39. Holm A, Rise F, Sessler N, Sollid LM, Undheim K, Fleckenstein B. Specific modification of peptide-bound citrulline residues. Analytical Biochemistry 2006; 352: 68-76.
40. Evans RM. Intermediate filaments and lipoprotein cholesterol. Trends Cell Biol 1994; 4: 149-151.
41. Mclnroy L, Määttä A. Down-regulation of vimentin expression inhibits carcinoma cell migration and adhesion. Biochem Biophys Res Commun 2007; 360: 109-114.
42. Benes P, Macecková V, Zdráhal Z, Konecná H, Zahradnícková E, Muzík J, Smarda J. Role of vimentin in regulation of monocyte/ macrophage differentiation. Differentiation 2006; 74: 265-276.
43. Geerts A, Eliasson C, Niki T, Wielant A, Vaeyens F, and Pekny M. Formation of normal desmin intermediate filaments in mouse hepatic stellate cells requires vimentin. Hepatology 2001; 33: 177-188.
44. Miyata E, Masuya M, Yoshida S, Nakamura S, Kato K, Sugimoto Y, Shibasaki T, Yamamura K, Ohishi K, Nishii K, Ishikawa F, Shiku H, Katayama N. Hematopoietic origin of hepatic stellate cells in the adult liver. Blood 2008; 111: 2427-2435.
45. Zhen EY, Brittain IJ, Laska DA, Mitchell PG, Sumer EU, Karsdal MA, and Duffin KL. Characterization of metalloprotease cleavage products of human articular cartilage. Arthritis Rheum 2008; 58: 2420-2431.
46. Abheen S, Olusi SO, and George S. Serum anti-modified citrullinated vimentin antibody concentration is associated with liver fibrosis in patients with chronic hepatitis. Hepatic Medicine: Evidence and Research 2011; 3: 13-18.
47. Zhao L, Burt AD. The diffuse stellate cell system. J Mol Histol 2007; 38: 53-64.
48. Combet C, Blanchet C, Geourjon C, and Deleage G. NPS@: network protein sequence analysis. Trends Biochem Sci 2000; 25: 147-150.
49. Gefter ML, Margulies DH, and Scharff MD. A simple method for polyethylene glycolpromoted hybridization of mouse myeloma cells. Somatic Cell Genet 1977; 3: 231-236.
50. ir-Kirk TL and Senior RM. Fragments of extracellular matrix as mediators of inflammation. Int J Biochem Cell Biol 2008; 40: 1101-1110.